LENSAR, Inc. (LNSR): Revenue
$58.44M
Year ended 2025-12-31
$60.26M
Trailing 12 months to 2026-06-30
+18.2%
3-year compound annual growth
+17.2%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $58.44M | +9.2% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $53.49M | +26.9% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $42.16M | +19.2% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $35.36M | +2.6% | 2024-03-04, From 2022-01-01 |
| 2021-12-31 | $34.46M | +30.6% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $26.38M | -13.6% | 2022-03-03, From 2020-01-01 |
| 2019-12-31 | $30.53M | n/a | 2021-03-12, From 2019-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | 2025-12-31 | $58.44M | +9.2% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $56.65M | +10.4% |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | 2025-12-31 | $61.79M | -36.2% |
| Apyx Medical Corp (APYX) | 2025-12-31 | $52.84M | +9.9% |
| Carlsmed, Inc. (CARL) | 2025-12-31 | $50.51M | +85.9% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $71.61M | +11.5% |
| Shoulder Innovations, Inc. (SI) | 2025-12-31 | $47.32M | +49.6% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $45.15M | +53.4% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $77.36M | -3.1% |
Compare LNSR, CVRX, MHUAF, APYX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗